推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 我國(guó)的中藥材商品供應(yīng)主要依靠野生資源。從20世紀(jì)50年代起，我國(guó)大力發(fā)展中藥材的栽培和養(yǎng)殖。雖然目前仍有70%左右的中藥材品種來(lái)自野生資源，但30%來(lái)自栽培和養(yǎng)殖的藥材品種，其生產(chǎn)量卻占到了中藥材供應(yīng)量的70%以上。
截至2012年，全國(guó)藥材種植總面積約2100萬(wàn)畝(不含林下種植面積)，《中華人民共和國(guó)藥典》(2010年版)收載藥材品種達(dá)616個(gè)，種植養(yǎng)殖品種近在300個(gè)，其中生產(chǎn)供應(yīng)以栽培(養(yǎng)殖)為主的近200種，占常規(guī)使用品種的40%以上，基本滿足了中醫(yī)藥臨床用藥、中藥產(chǎn)業(yè)和健康服務(wù)業(yè)快速發(fā)展的需要。
在行業(yè)層面，相關(guān)基地認(rèn)證的推行有效提升了藥材種植的規(guī)范化水平。截至2014年底，141家企業(yè)66個(gè)品種152個(gè)中藥材種植基地通過(guò)國(guó)家食品藥品監(jiān)督管理總局GAP認(rèn)證。中國(guó)中藥協(xié)會(huì)中藥材種植養(yǎng)殖專(zhuān)業(yè)委員會(huì)也積極在會(huì)員內(nèi)部開(kāi)展“優(yōu)質(zhì)道地藥材示范基地”評(píng)選活動(dòng)，截至目前共評(píng)出38個(gè)品種40個(gè)優(yōu)質(zhì)道地藥材示范基地。
